Latest filing published 28 Jul 2022 for Small Pharma Inc. (formerly, Unilock Capital Corp.), €1,792.
This profile gathers the share dealings of Lyne Fortin in Small Pharma Inc. (formerly, Unilock Capital Corp.). In total, 16 filings cover trades dated from 6 May 2021 to 28 July 2022.
On the market, this insider has only ever bought: 16 purchases, €31k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2022: 9 purchases and no sales on the market.
The median purchase comes to €1,515. No cluster: in 16 purchases, no other insider of the company bought within 30 days.
On 28 July 2022 came the latest disclosure, an open-market purchase for €853 in Small Pharma Inc. (formerly, Unilock Capital Corp.). Most trades are made public on the day they happen. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations